IO Biotech (IOBT) announced that the company intends to explore a range of strategic alternatives to maximize stockholder value. Strategic alternatives that may be evaluated

Lisata Therapeutics (LSTA) announced that it has entered into a binding term sheet to be acquired by Kuva Labs. Kuva will commence a tender offer

Bloomberg reported that Qiagen NV (QGEN), the European molecular testing firm, is weighing strategic options including a potential sale amid fresh takeover interest. The company

Reuters reported that Devon Energy (DVN) and Coterra Energy (CTRA) are exploring a potential merger, in a deal that could create one of the largest

CASI Pharmaceuticals (CASI) disclosed that Director Wei-Wu He submitted a preliminary non-binding proposal to acquire all publicly held shares of the company for $1.15 per

BARK (BARK) announced that its Board has received a preliminary, non-binding proposal from Great Dane Ventures, LLC, a stockholder group led by CEO Matt Meeker.

The Wall Street Journal reported that AbbVie (ABBV) is in advanced talks to buy cancer-drug biotech Revolution Medicines (RVMD). A deal could come together soon.

Bloomberg reported that Henkel has submitted a takeover offer for Olaplex Holdings (OLPX). Olaplex and Henkel are in talks about a potential deal that could

The Wall Street Journal reported that Eli Lilly (LLY) is in advanced talks to acquire Ventyx Biosciences (VTYX) for more than $1 billion. A deal

Stratus Properties (STRS) announced that its Board has initiated a process to explore strategic alternatives to maximize shareholder value with the assistance of outside, independent

The Wall Street Journal reported that activist investor Irenic Capital Management has built a stake of more than 3% in Integer Holdings (ITGR) and is

PetMed Express (PETS) announced that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments to acquire all of the outstanding shares of